AscellaHealth: Ensuring Specialty Pharmacy Value for Patients with High-cost Rare Diseases

By National Alliance posted 04-09-2021 10:24

  

Focusing on patients with high-cost rare disease states such as hemophilia, hereditary angioedema, and multiple sclerosis, AscellaHealth ensures that these patients receive faster access to the right therapies and full-spectrum support to improve health outcomes while reducing costs associated with avoidable hospitalizations and complications.

0 comments
7 views

Permalink